HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Albert D Windhorst Selected Research

tariquidar (XR9576)

12/2021Novel Thienopyrimidine-Based PET Tracers for P2Y12 Receptor Imaging in the Brain.
1/2015A comparative PET imaging study with the reversible and irreversible EGFR tyrosine kinase inhibitors [(11)C]erlotinib and [(18)F]afatinib in lung cancer-bearing mice.
4/2013Tariquidar and elacridar are dose-dependently transported by P-glycoprotein and Bcrp at the blood-brain barrier: a small-animal positron emission tomography and in vitro study.
12/2012Altered GABAA receptor density and unaltered blood-brain barrier transport in a kainate model of epilepsy: an in vivo study using 11C-flumazenil and PET.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Albert D Windhorst Research Topics

Disease

37Neoplasms (Cancer)
09/2022 - 11/2007
30Alzheimer Disease (Alzheimer's Disease)
01/2021 - 02/2009
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 01/2012
11Cognitive Dysfunction
12/2020 - 01/2013
9Breast Neoplasms (Breast Cancer)
01/2022 - 04/2013
9Dementia (Dementias)
01/2021 - 01/2013
7Neuroinflammatory Diseases
12/2021 - 03/2013
7Epilepsy (Aura)
01/2017 - 01/2011
6Rheumatoid Arthritis
01/2022 - 03/2013
6Arthritis (Polyarthritis)
01/2022 - 03/2013
6Neurodegenerative Diseases (Neurodegenerative Disease)
10/2020 - 02/2007
5Neoplasm Metastasis (Metastasis)
01/2021 - 10/2018
4Inflammation (Inflammations)
09/2022 - 10/2014
4Prostatic Neoplasms (Prostate Cancer)
12/2019 - 03/2015
4Schizophrenia (Dementia Praecox)
08/2016 - 11/2008
4Hypoxia (Hypoxemia)
07/2015 - 08/2011
4Lung Neoplasms (Lung Cancer)
01/2015 - 07/2011
3Fibrosis (Cirrhosis)
12/2021 - 03/2009
3Disease Progression
12/2021 - 06/2012
3Multiple Sclerosis
01/2020 - 12/2017
3Nervous System Diseases (Neurological Disorders)
01/2018 - 01/2005
3Amyloid Plaque
01/2013 - 11/2008
2Necrosis
12/2021 - 11/2007
2Atrophy
11/2020 - 05/2014
2Glioma (Gliomas)
07/2018 - 03/2015
2Glioblastoma (Glioblastoma Multiforme)
07/2018 - 03/2015
2Celiac Disease (Celiac Sprue)
01/2017 - 01/2017
2Cardiomyopathies (Cardiomyopathy)
12/2016 - 11/2015
2Mental Disorders (Mental Disorder)
08/2016 - 03/2015
2Temporal Lobe Epilepsy
10/2014 - 12/2012
2Synovitis
03/2014 - 03/2013
2Seizures (Absence Seizure)
08/2013 - 01/2011
1Respiratory Tract Infections (Respiratory Tract Infection)
09/2022
1Infections
09/2022
1Pneumonia (Pneumonitis)
09/2022
1Squamous Cell Carcinoma of Head and Neck
01/2022
1Autoimmune Diseases (Autoimmune Disease)
01/2022
1Neoplasm Micrometastasis
12/2021
1Adenocarcinoma
12/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2021
1Hyperplasia
11/2021

Drug/Important Bio-Agent (IBA)

14Amyloid (Amyloid Fibrils)IBA
01/2021 - 01/2012
13Proteins (Proteins, Gene)FDA Link
12/2021 - 03/2013
13Member 1 Subfamily B ATP Binding Cassette TransporterIBA
12/2021 - 01/2005
12Biomarkers (Surrogate Marker)IBA
12/2021 - 11/2007
97- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA
01/2021 - 12/2017
7LigandsIBA
10/2020 - 03/2013
7Pharmaceutical PreparationsIBA
03/2015 - 01/2011
6Erlotinib Hydrochloride (CP 358,774)FDA Link
04/2022 - 01/2013
6Glucose (Dextrose)FDA LinkGeneric
06/2014 - 11/2007
5AfatinibIBA
04/2022 - 10/2014
52- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA
05/2014 - 06/2012
4N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA
09/2022 - 03/2014
4tariquidar (XR9576)IBA
12/2021 - 12/2012
4ErbB Receptors (EGF Receptor)IBA
01/2021 - 01/2013
4poly(ethylene glycol)-folateIBA
01/2020 - 03/2013
4Verapamil (Calan)FDA LinkGeneric
01/2017 - 01/2011
4Tyrosine Kinase InhibitorsIBA
01/2015 - 11/2012
4Docetaxel (Taxotere)FDA Link
08/2013 - 10/2010
3Folic Acid (Vitamin M)FDA LinkGeneric
01/2022 - 03/2013
3Trastuzumab (Herceptin)FDA Link
06/2021 - 04/2020
3Purinergic P2X7 ReceptorsIBA
01/2020 - 06/2014
3Peptides (Polypeptides)IBA
01/2018 - 10/2014
33- fluoro- 2- (4- ((2- nitro- 1H- imidazol- 1- yl)methyl)- 1H- 1,2,3- triazol- 1- yl)propan- 1- olIBA
07/2015 - 08/2011
3(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamideIBA
10/2014 - 11/2008
3PK 11195 (PK11195)IBA
03/2014 - 11/2008
32- (1- (6- ((2- fluoroethyl)(methyl)amino)- 2- naphthyl)ethylidene)malononitrileIBA
06/2012 - 11/2008
2Monoclonal AntibodiesIBA
01/2022 - 04/2020
2Phosphotransferases (Kinase)IBA
09/2021 - 06/2017
2florbetapirIBA
01/2021 - 01/2021
2Radioisotopes (Radionuclides)IBA
01/2021 - 04/2020
2Biological ProductsIBA
01/2020 - 03/2018
2AntigensIBA
12/2019 - 05/2019
2Androgen Receptors (Androgen Receptor)IBA
01/2019 - 10/2018
2EnzymesIBA
05/2018 - 01/2017
2Protein Glutamine gamma Glutamyltransferase 2IBA
05/2018 - 01/2017
2Carbon-11IBA
01/2018 - 06/2017
2methylated bovine serum albumin (MBSA)IBA
01/2018 - 03/2014
2Methotrexate (Mexate)FDA LinkGeneric
01/2018 - 01/2018
2Contrast MediaIBA
12/2016 - 04/2014
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
08/2016 - 03/2015
2carbogenIBA
07/2015 - 08/2011
2Oxygen (Dioxygen)IBA
07/2015 - 08/2011
2Niacinamide (Nicotinamide)FDA LinkGeneric
07/2015 - 08/2011
2fluoroazomycin arabinosideIBA
11/2014 - 10/2013
2Indicators and Reagents (Reagents)IBA
10/2014 - 11/2007
2Kainic Acid (Kainate)IBA
12/2012 - 01/2011
1Transforming Growth Factors (Transforming Growth Factor)IBA
09/2022
14- ((3- bromophenyl)amino)- 6,7- dimethoxyquinazolineIBA
04/2022
1Folate Receptor 2IBA
01/2022
1RadiopharmaceuticalsIBA
12/2021
1Parathyroid Hormone (Parathormone)IBA
11/2021
1Cinacalcet (Sensipar)FDA Link
11/2021

Therapy/Procedure

21Therapeutics
01/2022 - 11/2008
3Radiotherapy
07/2015 - 11/2007
3Drug Therapy (Chemotherapy)
12/2013 - 01/2012
2Precision Medicine
12/2021 - 01/2021
2Castration
01/2019 - 10/2018
1Combined Modality Therapy
12/2021
1Neoadjuvant Therapy
12/2021